// App-Quantinova.ai

PO‐003 : Modifications in receptor affinity drives efficacy of CARCD123 T cells in AML

Researchers

Presenter

  • S Chitre

Principal Investigators

  • J Gaken

  • G Mufti

Medical Centers

  • Department of Haematological Medicine, King's College London, London, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • N/A

Biomarkers

  • Peripheral blood mononuclear cell

  • Cluster of Differentiation 2AP

  • Cluster of Differentiation 34

  • Cluster of Differentiation 4

  • Cluster of differentiation 8A

  • Coxsackie Virus And Adenovirus Receptor

  • Interleukin-2

  • Tumor necrosis factor

Drug/Treatment

  • Interleukin

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved